drugset / Trial / NCT04825730

Follow-up Study for Participants of Jointstem Investigator Initiated Trial by Arthroscopy

NCT04825730

Not yet recruiting 14 enrolled R-Bio
NaSingle-groupOpen-labelTreatment

Summary

This clinical trial is conducted to assess the long-term safety of "jointstem" in patients with degenerative knee arthritis who participated in the previous BS-JS-IIT1 investigator initiated trial.

Timeline

Start
2023-12-01
Primary completion
2028-12-01
Completion
2029-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous adipose-derived mesenchymal stem cells Cell therapy

Indications